BIOMAT Database Logo BIOMAT Database Logo

Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. 1995

S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
Department of Pathology, University of Alabama at Birmingham 35294-0019, USA.

Transforming growth factor-beta (TGF-beta) is a potent growth regulatory protein secreted by virtually all cells in a latent form. A major mechanism of regulating TGF-beta activity occurs through factors that control the processing of the latent to the biologically active form of the molecule. We have shown previously that thrombospondin 1 (TSP1), a platelet alpha-granule and extracellular matrix protein, activates latent TGF-beta via a protease- and cell-independent mechanism and have localized the TGF-beta binding/activation region to the type 1 repeats of platelet TSP1. We now report that recombinant human TSP1, but not recombinant mouse TSP2, activates latent TGF-beta. Activation was further localized to the unique sequence RFK found between the first and the second type 1 repeats of TSP1 (amino acids 412-415) by the use of synthetic peptides. A peptide with the corresponding sequence in TSP2, RIR, was inactive. In addition, a hexapeptide GGWSHW, based on a sequence present in the type 1 repeats of both TSP1 and TSP2, inhibited the activation of latent TGF-beta by TSP1. This peptide bound to 125I-active TGF-beta and inhibited interactions of TSP1 with latent TGF-beta. TSP2 also inhibited activation of latent TGF-beta by TSP1, presumably by competitively binding to TGF-beta through the WSHW sequence. These studies show that activation of latent TGF-beta is mediated by two sequences present in the type 1 repeats of TSP1, a sequence (GGWSHW) that binds active TGF-beta and potentially orients the TSP molecule and a second sequence (RFK) that activates latent TGF-beta. Peptides based on these sites have potential therapeutic applications for modulation of TGF-beta activation.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked

Related Publications

S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
Activation of platelet-transforming growth factor beta-1 in the absence of thrombospondin-1.
June 2000, The Journal of biological chemistry,
S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
Thrombospondin-1 promotes fibroblast-mediated collagen gel contraction caused by activation of latent transforming growth factor beta-1.
April 2003, Journal of dermatological science,
S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
[Thrombospondin-1-dependent mechanism of transforming growth factor beta-1 activation in cultured human endothelial cells].
January 2004, Ukrains'kyi biokhimichnyi zhurnal (1999 ),
S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
Transforming growth factor-beta complexes with thrombospondin.
February 1992, Molecular biology of the cell,
S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor beta in human cancer cells--transcriptional activation and messenger RNA stabilization.
February 2002, Biochimica et biophysica acta,
S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta.
August 2004, The American journal of pathology,
S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
Growth regulation by transforming growth factor-beta.
January 1992, Cancer treatment and research,
S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.
January 2021, International journal of molecular sciences,
S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction.
April 1989, The Journal of biological chemistry,
S Schultz-Cherry, and H Chen, and D F Mosher, and T M Misenheimer, and H C Krutzsch, and D D Roberts, and J E Murphy-Ullrich
The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
October 1994, The Journal of biological chemistry,
Copied contents to your clipboard!